SLCO1B1 and pulmonary tuberculosis: To assess previously described pharmacogenetic effects in a new population, and evaluate the contribution of unexplored polymorphisms in other key metabolic processes, we assessed the impact of critical SNPs in the candidate genes SLCO1B1, AADAC, and CES-1 on plasma exposure to RIF among Malawian adults with smear-positive pulmonary TB.